Pfizer stands high
Source: Agencies |
August 16, 2011, Tuesday
|
Print Edition
Print Edition
PFIZER Inc yesterday said it won a patent infringement case against the United States unit of Teva Pharmaceuticals Industries Ltd, preventing Teva from launching a generic version of Pfizer's erectile dysfunction drug Viagra until October 2019.
Pfizer, the world's biggest drugmaker, said litigation on the same patent remains pending against other generic companies, but no trials are scheduled in those cases.
Pfizer, the world's biggest drugmaker, said litigation on the same patent remains pending against other generic companies, but no trials are scheduled in those cases.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
